
FGEN
FibroGen Inc
$12.23
+$0.92(+8.13%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$46.55M
Volume
39.99K
52W Range
$4.50 - $21.95
Target Price
$43.00
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $180.8M | $179.6M | $131.0M | $213.0M | $256.6M | $176.3M | $235.3M | $140.7M | $46.8M | $29.6M | ||
Total Revenue | $180.8M | $183.2M | $131.0M | $213.0M | $256.6M | $176.3M | $235.3M | $140.7M | $46.8M | $29.6M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | -- | -- | -- | -- | -- | $8.9M | $12.9M | $20.3M | $4.0M | $15.6M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $180.8M | $179.6M | $131.0M | $213.0M | $256.6M | $167.4M | $222.4M | $120.5M | $42.8M | $14.1M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-258.5M | $-233.2M | $-248.3M | $-299.7M | $345.9M | $368.2M | $523.8M | $421.5M | $353.0M | $145.0M | ||
Research & Development | $214.1M | $187.2M | $196.5M | $235.8M | $209.3M | $252.9M | $387.0M | $296.8M | $266.5M | $95.7M | ||
Research Expense | $214.1M | $187.2M | $196.5M | $235.8M | $209.3M | $252.9M | $387.0M | $296.8M | $266.5M | $95.7M | ||
Selling, General & Administrative | $44.4M | $46.0M | $51.8M | $63.8M | $135.5M | $106.4M | $136.8M | $124.7M | $86.5M | $49.3M | ||
Selling & Marketing Expenses | -- | -- | -- | $63.8M | -- | -- | $12.9M | $20.3M | -- | -- | ||
General & Administrative Expenses | $44.4M | $46.0M | $51.8M | $63.8M | $135.5M | $106.4M | $136.8M | $124.7M | $86.5M | $49.3M | ||
Salaries & Wages | $-27.7M | $-32.1M | $-37.5M | $-52.1M | -- | $8.9M | -- | -- | $50.8M | $25.2M | ||
Depreciation & Amortization | $-5.7M | $-6.0M | $-6.1M | $-6.6M | $11.1M | $11.7M | $10.2M | $10.0M | $9.5M | $2.7M | ||
Depreciation & Amortization | $-5.7M | $-6.0M | $-6.1M | $-6.6M | $11.1M | $11.7M | $10.2M | $10.0M | $9.5M | $2.7M | ||
Amortization | -- | -- | -- | -- | $10.3M | $10.4M | $4.6M | $587.0K | $412.0K | -- | ||
Securities Amortization | -- | -- | -- | -- | -- | -- | -- | $20.3M | -- | -- | ||
Other Operating Expenses | -- | -- | -- | -- | $-1.1M | $12.3M | $14.7M | $17.1M | $15.2M | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $-77.6M | $-53.7M | $-117.3M | $-86.7M | $-89.3M | $-191.9M | $-288.5M | $-301.0M | $-322.7M | $-150.4M | ||
EBITDA | $-65.8M | $-42.3M | $-102.9M | $-68.6M | $-56.0M | $-164.3M | $-273.7M | $-282.8M | $-305.2M | $-142.5M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $11.0M | $10.7M | $9.7M | $11.0M | $2.9M | $2.4M | $2.2M | $1.4M | $8.1M | $8.2M | ||
Intinc | $3.1M | $2.6M | $6.4M | $11.6M | $15.5M | $5.6M | -- | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | $-7.9M | $-8.1M | $-3.3M | $577.0K | $12.7M | $-2.4M | $-1.1M | $-6.2M | $-8.1M | $-8.2M | ||
Other Income/Expense | -- | -- | -- | -- | -- | $-5.4M | $71.0K | $-9.2M | $-7.6M | $-5.3M | ||
Other Special Charges | -- | -- | -- | -- | -- | $5.6M | $-1.1M | $7.6M | $7.6M | $5.3M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | -- | $12.6M | $19.5M | ||
Special Income Charges | -- | -- | -- | -- | -- | -- | -- | -- | $-12.6M | $-19.5M | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-74.5M | $-51.0M | $-110.8M | $-75.1M | $-73.8M | $-186.3M | $-288.5M | $-293.4M | $-315.1M | $-145.1M | ||
Pre-Tax Income | $-85.5M | $-61.8M | $-120.6M | $-86.1M | $-76.6M | $-188.7M | $-290.7M | $-294.9M | $-323.2M | $-153.4M | ||
INCOME TAX | ||||||||||||
Tax Provision | $242.0K | $-71.0K | $321.0K | $304.0K | $328.0K | $360.0K | $347.0K | $358.0K | $-252.0K | $-269.0K | ||
NET INCOME | ||||||||||||
Net Income | $-85.8M | $-61.7M | $-120.9M | $-86.4M | $-77.0M | $-189.3M | $-290.0M | $-293.7M | $-284.2M | $-47.6M | ||
Net Income (Continuing Operations) | $-85.8M | $-61.7M | $-120.9M | $-86.4M | $-77.0M | $-189.3M | $-290.0M | $-293.7M | $-323.0M | $-153.1M | ||
Net Income (Discontinued Operations) | $-85.8M | $-61.7M | $-120.9M | $-86.4M | $-77.0M | $-189.3M | $-290.0M | $-293.7M | $-284.2M | $-47.6M | ||
Net Income (Common Stockholders) | $-85.8M | $-61.7M | $-120.9M | $-86.4M | $-74.7M | $-189.3M | $-290.0M | $-293.7M | $-284.2M | $-47.6M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-135.9M | ||
TOTALS | ||||||||||||
Total Expenses | $-258.5M | $-233.2M | $-248.3M | $-299.7M | $345.9M | $377.1M | $536.7M | $441.8M | $356.9M | $160.6M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $2.4M | $2.5M | $2.9M | $3.4M | $3.5M | $3.6M | $3.7M | $3.7M | $3.9M | $100.0M | ||
Average Shares Outstanding (Diluted) | $2.4M | $2.5M | $2.9M | $3.4M | $3.5M | $3.6M | $3.7M | $3.7M | $3.9M | $100.0M | ||
Shares Outstanding | $2.5M | $2.6M | $3.3M | $3.4M | $3.5M | $3.7M | $3.7M | $3.8M | $4.0M | $100.9M | ||
Basic EPS | -- | -- | -- | -- | $-22.25 | $-52.75 | $-78.5 | $-78.5 | $-73 | $-0.48 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-22.25 | $-52.75 | $-78.5 | $-78.5 | $-73 | $-1.53 | ||
Diluted EPS | $-35.5 | $-24.5 | $-43.25 | $-25.75 | $-22.25 | $-52.75 | $-78.5 | $-78.5 | $-73 | $-0.48 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | -- | $-78.5 | $-73 | $-1.53 | ||
OTHER METRICS | ||||||||||||
Basic Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.05 | ||
Diluted Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.05 | ||
Earnings from equity interest | -- | -- | -- | -- | -- | $-202.0K | $1.0M | $1.6M | $2.6M | -- | ||
Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | $-202.0K | $1.0M | $1.6M | $2.6M | -- | ||
Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.7M | ||
Marketing Expense | -- | -- | -- | -- | -- | -- | -- | $20.3M | -- | -- | ||
Minority Interests | -- | -- | -- | -- | $535.4M | $441.4M | -- | -- | -- | -- | ||
Net Income Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $38.7M | $105.5M | ||
Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | -- | -- | -- | -- | $38.7M | $105.5M | ||
Other Gand A | $44.4M | $46.0M | $51.8M | $63.8M | $135.5M | $106.4M | $136.8M | $124.7M | $86.5M | $49.3M | ||
Rent And Landing Fees | $44.4M | $46.0M | $51.8M | $63.8M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | -- | -- | -- | $63.8M | -- | -- | $12.9M | -- | -- | -- | ||
Restruct | -- | -- | -- | -- | -- | -- | -- | -- | $12.6M | $19.5M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | FGEN | $12.23 | +8.1% | 39.99K |
3 | ||||
4 | ||||
5 | ||||
6 |